AstraZeneca PLC and Oxford University have been given the green light to restart their coronavirus vaccine trial in the UK, following a safety review.
The partners can now re-commence the trial of AZD1222 following confirmation by the Medicines Health Regulatory Authority (MHRA), and announced...






